Seth Levy

Company: Modalis Therapeutics

Job title: Sr. Director, Bioprocess Development

Seminars:

PANEL: Using Orthogonal Approaches to Increase Assay Resolution & Accurately Quantify Empty-Full Ratios 2:30 pm

Understanding how to correlate orthologous methods, such as NGS, to qualify AUC and determine genome content Validating ratios by identifying trends appearing from using orthogonal methods in the absence of adequate reference standard materials Determining how to holistically apply empty-full characterization technology to build a fuller picture of genome integrityRead more

day: Day One PM - B

Using In-Process Analytics to Monitor Emerging CQAs & Guide Upstream Process Development 9:00 am - 12:00 pm

• Determine what kind of in-process analysis is suitable and sufficient for real-time monitoring during manufacturing and effective process development • Discuss relevant CQAs to incorporate into your in-process analytical strategy • Understand to what extent it is beneficial to measure novel CQAs such as empty-full ratios compared to traditional parameters such as genome titer…Read more

day: Pre-Conference Day, Workshop C